Intended for healthcare professionals


Widening screening to detect Chlamydia trachomatis is more important than using DNA methods

BMJ 1999; 318 doi: (Published 22 May 1999) Cite this as: BMJ 1999;318:1416
  1. Alan Herring, Head (,
  2. Owen Caul, Consultant virologist,
  3. Ian Paul, Medical laboratory scientific officer,
  4. Patrick Horner, Consultant physician
  1. PHLS Genitourinary Infections Reference Laboratory
  2. Bristol Public Health Laboratory, Bristol BS2 8EL
  3. Milne Centre, Bristol Royal Infirmary, Bristol BS2 8HW

    EDITOR—The letter from Taylor-Robinson and Robinson on the use of DNA amplification methods for diagnosing chlamydial infections raises several difficult issues.1 The cost of changing to such methods is substantial: we estimate that an additional £5m a year would be required for the current workload in genitourinary medicine. In addition, the substantial costs of training, additional space, and gaining formal accreditation would have to be met before the methods could be …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription